A Phase 1, Open-label, Single Cohort, Two-Period Fixed Sequence Study to Assess the Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg Twice Daily in Subjects With Type 2 Diabetes Mellitus
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2015
At a glance
- Drugs Ranolazine (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 10 Jul 2012 Actual end date (1 March 2012) added as reported by ClinicalTrials.gov record.
- 13 Mar 2012 New trial record
- 01 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.